Ride Therapeutics is a recently formed transatlantic biotechnology company with the mission of unlocking the full potential of mRNA & gene editing therapeutics through targeted & tunable delivery of these modalities. Founded by world-leading scientists from Harvard University & the University of Cambridge, Ride’s unique technology platform provides an entirely new approach to solving the delivery challenge at the molecular level. Powered by micro- and nano-engineering coupled to advanced data science, Ride is building the capability to deliver any molecular cargo, to any cell type, with a tunable release profile.
Company Details
- Employees
- 10
- Address
- Cambridge, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Cambridge
Ride Therapeutics Questions
Ride Therapeutics's LinkedIn profile is https://uk.linkedin.com/company/ride-therapeutics
Ride Therapeutics has
10 employees.
View email and phone details for 10
employees at Ride Therapeutics.
Ride Therapeutics's industry is
Biotechnology Research
Ride Therapeutics's top competitors are
Transition Bio, Inc.,
Relay Therapeutics,
Engivent,
Vertex Pharmaceuticals,
Nereid Therapeutics,
Wavebreak,
Dewpoint Therapeutics,
Exo Therapeutics,
Bicycle Therapeutics,
Faze Medicines.
Ride Therapeutics's categories are Biotechnology Research
